MORRIS PLAINS, N.J., Dec. 3, 2007 (PRIME NEWSWIRE) -- Immunomedics, Inc. (NasdaqGM:IMMU - News), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that four presentations will be given at the 49th Annual Meeting of the American Society of Hematology (ASH), scheduled for December 8 - 11, 2007, in Atlanta, Georgia. The schedule and meeting places for the poster sessions, together with the abstract and board numbers are listed below:
